These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24351753)

  • 41. [Tularemia seroprevalence in the risky population living in both rural and urban areas of Erzurum].
    Yazgı H; Uyanık MH; Ertek M; Kılıç S; Kireçci E; Ozden K; Ayyıldız A
    Mikrobiyol Bul; 2011 Jan; 45(1):67-74. PubMed ID: 21341161
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R; Harris G; Conlan JW; Chen W
    Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Prevalence of antibodies to Francisella tularensis in forest workers from different regions of Poland].
    Rastawicki W; Kurowska J; Hermanowska-Szpakowicz T; Pancewicz SA; Kondrusik M; Jagielski M
    Med Dosw Mikrobiol; 2006; 58(3):207-15. PubMed ID: 17340995
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Native outer membrane proteins protect mice against pulmonary challenge with virulent type A Francisella tularensis.
    Huntley JF; Conley PG; Rasko DA; Hagman KE; Apicella MA; Norgard MV
    Infect Immun; 2008 Aug; 76(8):3664-71. PubMed ID: 18505805
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
    Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S
    Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Seroprevalence study of Francisella tularensis among hunters in Germany.
    Jenzora A; Jansen A; Ranisch H; Lierz M; Wichmann O; Grunow R
    FEMS Immunol Med Microbiol; 2008 Jul; 53(2):183-9. PubMed ID: 18462387
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Production of anti-LPS IgM by B1a B cells depends on IL-1β and is protective against lung infection with Francisella tularensis LVS.
    del Barrio L; Sahoo M; Lantier L; Reynolds JM; Ceballos-Olvera I; Re F
    PLoS Pathog; 2015 Mar; 11(3):e1004706. PubMed ID: 25768794
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Francisella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy.
    Savitt AG; Mena-Taboada P; Monsalve G; Benach JL
    Clin Vaccine Immunol; 2009 Mar; 16(3):414-22. PubMed ID: 19176692
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detoxified endotoxin vaccine (J5dLPS/OMP) protects mice against lethal respiratory challenge with Francisella tularensis SchuS4.
    Gregory SH; Chen WH; Mott S; Palardy JE; Parejo NA; Heninger S; Anderson CA; Artenstein AW; Opal SM; Cross AS
    Vaccine; 2010 Apr; 28(16):2908-15. PubMed ID: 20170768
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of an immunochromatographic test for rapid and reliable serodiagnosis of human tularemia and detection of Francisella tularensis-specific antibodies in sera from different mammalian species.
    Splettstoesser W; Guglielmo-Viret V; Seibold E; Thullier P
    J Clin Microbiol; 2010 May; 48(5):1629-34. PubMed ID: 20220165
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
    Baron SD; Singh R; Metzger DW
    Infect Immun; 2007 May; 75(5):2152-62. PubMed ID: 17296747
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A typical preparation of Francisella tularensis O-antigen yields a mixture of three types of saccharides.
    Wang Q; Shi X; Leymarie N; Madico G; Sharon J; Costello CE; Zaia J
    Biochemistry; 2011 Dec; 50(50):10941-50. PubMed ID: 22091710
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Performance of seven serological assays for diagnosing tularemia.
    Chaignat V; Djordjevic-Spasic M; Ruettger A; Otto P; Klimpel D; Müller W; Sachse K; Araj G; Diller R; Tomaso H
    BMC Infect Dis; 2014 May; 14():234. PubMed ID: 24885274
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia.
    Hickey AJ; Hazlett KR; Kirimanjeswara GS; Metzger DW
    Vaccine; 2011 Sep; 29(40):6941-7. PubMed ID: 21803089
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain.
    Richard K; Mann BJ; Stocker L; Barry EM; Qin A; Cole LE; Hurley MT; Ernst RK; Michalek SM; Stein DC; Deshong P; Vogel SN
    Clin Vaccine Immunol; 2014 Feb; 21(2):212-26. PubMed ID: 24351755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral live vaccine strain-induced protective immunity against pulmonary Francisella tularensis challenge is mediated by CD4+ T cells and antibodies, including immunoglobulin A.
    Ray HJ; Cong Y; Murthy AK; Selby DM; Klose KE; Barker JR; Guentzel MN; Arulanandam BP
    Clin Vaccine Immunol; 2009 Apr; 16(4):444-52. PubMed ID: 19211773
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.
    Richard K; Mann BJ; Qin A; Barry EM; Ernst RK; Vogel SN
    Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28077440
    [No Abstract]   [Full Text] [Related]  

  • 58. Antigen-specific B-1a antibodies induced by Francisella tularensis LPS provide long-term protection against F. tularensis LVS challenge.
    Cole LE; Yang Y; Elkins KL; Fernandez ET; Qureshi N; Shlomchik MJ; Herzenberg LA; Herzenberg LA; Vogel SN
    Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4343-8. PubMed ID: 19251656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Francisella tularensis aortitis.
    Briere M; Kaladji A; Douane F; Breux JP; Touroult-Jupin P; Boisset S; Edouard S; Biron C; Boutoille D
    Infection; 2016 Apr; 44(2):263-5. PubMed ID: 26189939
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS.
    Li J; Ryder C; Mandal M; Ahmed F; Azadi P; Snyder DS; Pechous RD; Zahrt T; Inzana TJ
    Microbiology (Reading); 2007 Sep; 153(Pt 9):3141-3153. PubMed ID: 17768257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.